Neurotechnology and Brain Stimulation in Pediatric Psychiatric and Neurodevelopmental Disorders. Este artículo no está disponible.Neurotechnology and Brain Stimulation in Pediatric Psychiatric and Neurodevelopmental Disorders

Neurotechnology and Brain Stimulation in Pediatric Psychiatric and Neurodevelopmental Disorders provides a comprehensive overview of neurotechnological devices as potential treatments for psychiatric and neurodevelopmental disorders in children and adolescents. Many neuropsychiatric disorders are covered such as Autism Spectrum Disorder, ADHD, Depression, Tourette’s Syndrome, and OCD. Different device-based treatments are discussed such as Transcranial Magnetic Stimulation, Transcranial Direct Current Stimulation, Deep Brain Stimulation, Chronotherapy, and Neurofeedback.

Dr. Lindsay Oberman is the Clinical Program Leader for the Center for Neuroscience and Regenerative Medicine, Henry M. Jackson Foundation for the Advancement of Military Medicine, Rockville, Maryland. Dr. Oberman's research interest lies in using electrophysiological techniques (such as EEG and TMS and tDCS) to investigate and modulate neural circuits whose dysfunction may account for the behavioral pathology seen in autism spectrum disorder with the long-term goal of developing novel therapeutic interventions. She is an internationally recognized expert in the use of noninvasive brain stimulation in neurodevelopmental disorders having authored over 20 peer-reviewed papers on the topic.

Dr. Enticott is a Professor of Psychology (Cognitive Neuroscience) and Director of the Cognitive Neuroscience Unit (CNU) in the School of Psychology, at Deakin University (Melbourne, Australia). Dr. Enticott’s work examines the neurobiological basis of social brain development and autism spectrum disorder (ASD) using a combination of neuroscience techniques (e.g., functional neuroimaging, electroencephalography, non-invasive brain stimulation). Dr. Enticott also conducts clinical trials assessing whether non-invasive brain stimulation (TMS, tDCS) can be used to improve both clinical and neurobiological aspects of ASD.